Earnings Call · Q1 FY2023·2023-05-04

Q1 23EPS +100.00%*·Rev n/aQ4 22EPS -100.00%*·Rev n/aQ3 22EPS +66.67%·Rev n/aQ2 22EPS +100.00%*·Rev n/a⚠ consensus missing

PUMA BIOTECHNOLOGY, INC. PBYI

Mariann Ohanesian — Senior Director of Investor Relations

Alan Auerbach — Chief Executive Officer, President and Chairman of the Board

Jeff Ludwig — Commercial Executive

Maximo Nougues — Chief Financial Officer

+20.7%1d on move date+18.8% vs SPY3d+20.3%5d+13.8%

Research tier

Behavioral profile computed for 4 speakers on this call.

Sign in to view the Behavioral Lean, the Behavioral Deviation Score, the speaker decomposition, and the novel forward-guidance phrases flagged on this call — each scored against the speaker's own prior-call baseline.

Behavioral data on every earnings call

Per-speaker language deviation, scored against each executive's own history. Explore more PBYI calls or request research access.

More PBYI calls Browse calls Request research access